Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorderJ Bradwejn, D KoszyckiPsychiatry Research|April 5, 2001
Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorderD Koszycki, J BradwejnScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|November 21, 2001
Cholecystokinin and panic disorder: past and future clinical research strategiesJ Bradwejn, D KoszyckiThe American Journal of Psychiatry|February 1, 1994
Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patientsJ Bradwejn, D KoszyckiCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 1, 1990
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorderJ Bradwejn, D Koszycki, G MeterissianArchives of General Psychiatry|July 1, 1991
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findingsJ Bradwejn, D Koszycki, C ShriquiEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1991
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteersD Koszycki, J Bradwejn, M BourinL'Encephale|September 1, 1991
[Is cholecystokinin a biological support in panic attacks?]M Bourin, J Bradwejn, D KoszyckiJournal of Psychiatry & Neuroscience : JPN|July 1, 1991
Dose ranging study of the effects of cholecystokinin in healthy volunteersJ Bradwejn, D Koszycki, M BourinPeptides|August 13, 1998
Decrease in short-term memory function induced by CCK-4 in healthy volunteersJ Shlik, D Koszycki, J BradwejnPageof 4